TipRanks
Go Ultimate55% OFF

Greenrise Global Brands Inc (XCX) AI Stock Analysis

TSE:XCX

Greenrise Global Brands Inc

(CNQX:XCX)

Select Model
Rating:37Underperform
Price Target:CAD 0.01â–¼(-10.00% Downside)
Action:initiatedcoverage
Date:01/13/26

Score driven by critical financial weaknesses including zero revenue, deepening negative equity, and high leverage risks; lack of technical data and negative valuation metrics reinforce high-risk profile.

Positive Factors
Strategic PartnershipsStrategic partnerships enhance distribution capabilities and market penetration, potentially driving long-term revenue growth and brand recognition.
Negative Factors
High LeverageHigh leverage and negative equity pose significant financial risks, limiting operational flexibility and increasing vulnerability to economic downturns.

Greenrise Global Brands Inc (XCX) vs. iShares MSCI Canada ETF (EWC)

-40%-30%-20%-10%0%10%20%30%TSE:XCX-33.33%EWC+21.27%Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
CAD 258.28K
Dividend Yield
―
Average Volume (3M)
1,050
Price to Earnings (P/E)
-1.0
Beta (1Y)
0.50
Revenue Growth
―
EPS Growth
―
Country
Canada
Employees
250
Sector
Healthcare
Sector Strength
51
Industry
Drug Manufacturers - Specialty & Generic

Greenrise Global Brands Inc Business Overview & Revenue Model

Company Description

Greenrise Global Brands Inc., operating through its various subsidiaries, serves as a pharmaceutical distributor, providing medical cannabis products to pharmacies throughout Germany. The company also offers a broad selection of CBD-infused items, su...

Greenrise Global Brands Inc Financial Statement Overview

Summary

Scores of 15, 12, and 18 for income statement, balance sheet, and cash flow reflect zero revenue, persistent losses, negative equity, high leverage, and volatile cash flows signaling severe financial distress.

Income Statement

15Very Negative

Balance Sheet

12Very Negative

Cash Flow

18Very Negative
Financial statement breakdown
BreakdownTTMMar 2025Mar 2024Jun 2023Mar 2022Mar 2021
Income Statement
Total Revenue0000452.87K105.20K
Gross Profit000043.32K-153
EBITDA-597.32K-542.80K-120.16K-752.81K-2.60M-2.06M
Net Income-807.54K-722.06K-298.91K-2.32M-3.64M-2.11M
Balance Sheet
Total Assets1,30593.53K441.82K1.25M252.94K371.56K
Cash, Cash Equivalents and Short-Term Investments1,30513.53K31.53K-619.68K27.45K60.45K
Total Debt2.73M2.62M2.80M3.15M1.90M1.08M
Total Liabilities2.88M2.79M3.06M3.56M2.26M1.34M
Stockholders Equity-2.88M-2.70M-2.61M-2.32M-2.00M-972.61K
Cash Flow
Free Cash Flow-87.44K-176.13K199.35K-1.08M-1.95M-1.88M
Operating Cash Flow-87.44K-176.13K199.35K-1.08M-1.89M-1.83M
Investing Cash Flow87.90K60.40K387.50K-531.00K-63.15K45.43K
Financing Cash Flow-16.43K97.73K-534.73K1.51M1.92M1.63M

Greenrise Global Brands Inc Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

TSE:XCX against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
TSE:XBRATSE:XBRA49NeutralCAD 420.72K-0.14-610.58%―――
TSE:XCXTSE:XCX37UnderperformCAD 258.28K-1.035.55%―――
TSE:CNTRTSE:CNTR37UnderperformCAD 579.89K-2.1313.65%――36.39%

* Healthcare Sector Average

Performance Comparison

-50%-25%0%25%50%TSE:XCXTSE:GHGTSE:CNTRTSE:XBRAFeb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
TSE:XCX and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TSE:XCXGreenrise Global Brands Inc0.01-0.00-33.33%
TSE:GHGGlobal Hemp0.020.000.00%
TSE:CNTRCentr Brands Corp.0.050.000.00%
TSE:XBRAXebra Brands Ltd.0.010.000.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Dec 30, 2025